Hospira Recalls IV Solution over Mold Concerns
Hospira Inc. initiated a nationwide recall for one lot of an intravenous solution after receiving a customer report of a spore-like matter resembling a mold found in the solution.
The recalled product is called Lactated Ringers and 5% Dextrose Injection, according to the U.S. Food and Drug Administration (FDA). It is used as a source of water, electrolytes, and calories or as an alkalizing agent in patients. The details of the packaging of the recalled lot of 5% Dextrose Injection include:
• 1000 ml flexible container
• lot number: 05-019-JT
• expiration date: May 1, 2013
• distributed nationwide between June 2011 and January 2012 to wholesalers/distributors, hospitals and pharmacies
The possible risks associated with the contaminated solution may include thrombosis, phlebitis, bacteremia, sepsis, septic shock and/or endocarditis, or a fatal infection.
No adverse events associated with this issue were reported to the company. Hospira has not been able to identify any quality issues with retention samples for this lot.
Those with an existing inventory have been asked to stop use and distribution of the product, and quarantine it immediately.